Citigroup Issues Positive Forecast for Sotera Health (NASDAQ:SHC) Stock Price

Sotera Health (NASDAQ:SHC) had its price objective lifted by investment analysts at Citigroup from $18.00 to $20.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s price target suggests a potential upside of 25.79% from the stock’s previous close.

Several other analysts also recently weighed in on the company. Barclays lifted their target price on Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research report on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $16.50.

Sotera Health Trading Up 3.1 %

SHC traded up $0.48 during trading on Wednesday, reaching $15.90. The company had a trading volume of 702,921 shares, compared to its average volume of 1,303,609. The stock has a market cap of $4.50 billion, a P/E ratio of 113.57 and a beta of 2.08. The business has a 50 day simple moving average of $15.94 and a 200-day simple moving average of $13.67. Sotera Health has a 52 week low of $10.71 and a 52 week high of $17.44. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The company had revenue of $285.47 million during the quarter, compared to the consensus estimate of $278.64 million. During the same quarter in the prior year, the business earned $0.18 earnings per share. The firm’s quarterly revenue was up 8.5% compared to the same quarter last year. On average, equities analysts anticipate that Sotera Health will post 0.64 EPS for the current fiscal year.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the sale, the director now owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 55.12% of the stock is owned by insiders.

Institutional Investors Weigh In On Sotera Health

A number of large investors have recently bought and sold shares of SHC. CWM LLC boosted its position in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after buying an additional 993 shares during the last quarter. GAMMA Investing LLC boosted its position in Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after buying an additional 1,660 shares during the last quarter. Point72 DIFC Ltd boosted its position in Sotera Health by 556.6% in the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after buying an additional 5,544 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in Sotera Health in the third quarter valued at approximately $91,000. Finally, Acadian Asset Management LLC boosted its position in Sotera Health by 728.0% in the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock valued at $111,000 after buying an additional 8,248 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.